Close

Follow Science2Sport

External Iliac Artery Intimal Fibrosis (or Endofibrosis) in Cyclists

Among elite endurance athletes, few diagnoses are as frustrating, or as easily missed, as external iliac artery intimal fibrosis (often called endofibrosis). It affects young, highly trained cyclists who otherwise look like the picture of cardiovascular health. Resting examination is usually normal, and yet performance quietly slips away.

For years, riders can describe a vague sense that "one leg just doesn't fire" at high intensity. Power drops on one side. Sprinting can feel asymmetrical. Too often, this is attributed to fatigue, biomechanics, or even psychology.

In reality, the limitation is vascular — and very real.

Endofibrosis is now a well-recognised condition in professional cycling and other endurance sports involving prolonged hip flexion. Awareness has grown, but delays in diagnosis remain common. For teams, clinicians, and athletes operating at the margins of performance, understanding this condition is essential.

Not atherosclerosis
Distinct non-inflammatory pathology
30–35 L/min
Elite cardiac output exposure
Left side predominant
Most cases unilateral
Normal resting exam
Exercise testing essential

Why Cyclists?

At its core, external iliac artery intimal fibrosis is a problem of extreme physiology meeting extreme mechanics.

Elite cyclists spend thousands of hours each year in sustained hip flexion, often in aggressive aerodynamic positions. The external iliac artery, which supplies blood to the working leg, must repeatedly lengthen, shorten, and bend with every pedal stroke. Over time, this combination of movement and fixation creates a perfect storm.

Add to that the enormous cardiac outputs seen in elite riders — often exceeding 30–35 L/min — and the external iliac artery is exposed to exceptionally high flow and shear stress. While healthy arteries adapt positively to training, in susceptible individuals this stress leads to maladaptive remodelling.

Pathophysiology: What Actually Goes Wrong

Despite the name, endofibrosis is not atherosclerosis. There are no lipid plaques, no calcification, and no traditional inflammatory process.

Instead, the condition is characterised by progressive thickening of the arterial intima, smooth muscle cell proliferation, increased collagen and connective tissue, and focal or segmental narrowing of the vessel.

The changes typically occur along the posterior or medial wall of the external iliac artery — exactly where mechanical stress is greatest during hip flexion.

Over time, the artery may also become elongated and relatively fixed by surrounding tissue (notably the psoas muscle), leading to dynamic kinking during high-intensity cycling. At rest, blood flow is adequate. At maximal effort, it is not.

The Classic Presentation "I feel fine until I go really hard — then the leg just dies." This explains why the condition is so often misattributed to fitness, fatigue, or biomechanics.

How It Presents

From a performance perspective, endofibrosis varies from subtle to devastating. Typical symptoms include exercise-induced thigh, buttock, or groin discomfort; a cramping or burning sensation at high intensity; sudden unilateral fatigue or weakness; and relatively rapid resolution of symptoms once effort stops.

Crucially, symptoms only appear above specific workloads — and initially only near maximal efforts. This threshold may become progressively lower as the problem evolves. Easy rides may feel normal. Even tempo efforts may be unaffected.

This is why riders often compensate unknowingly, altering biomechanics or pacing until performance drops become undeniable.

Most cases are unilateral, and the left side is affected more often — possibly related to anatomical asymmetry.

How Endofibrosis Symptoms Progress Over Time

Exercise intensity Disease progression Maximal / sprint Threshold / race pace Tempo / endurance Easy / recovery Early Sprints only affected Moderate Race pace affected Advanced Tempo rides affected Symptom threshold — drops progressively lower over time

Why Diagnosis Is So Often Missed

The biggest diagnostic trap is the normal resting exam. Pulses are usually normal. Skin and temperature are normal. Neurological examination is unremarkable. Resting ankle–brachial pressure index (ABPI) is normal.

Unless clinicians actively look for a flow limitation during maximal exercise, the diagnosis is easily overlooked.

Diagnosis

Diagnostic Pathway for Suspected Endofibrosis

Clinical suspicion Unilateral leg fatigue at high intensity Resting exam usually normal Post-exercise ABPI Bedside screening — compare both limbs Screening Drop on affected side? Duplex doppler ultrasound Exercise study — highly operator dependent Confirmation Positive findings? MRI No radiation, excellent anatomy or CT angiography Superb resolution, uses radiation Catheter angiography Gold standard — with hip flexion provocation Planning Surgical planning Definitive treatment for elite athletes

Exercise ABPI

One of the most useful screening tools is the post-exercise ABPI. When measured immediately after maximal effort, a significant drop on the affected side — especially compared with the contralateral limb — strongly suggests arterial flow limitation. However, it does not confirm the diagnosis.

This is easy to do and can aid in deciding whether to focus on EIAIF or investigate other potential diagnoses.

Duplex Doppler Ultrasound

Extremely useful — it can demonstrate increased flow velocities post-exercise in the affected limb, and visualise kinking, particularly with hip flexion. However, it is highly operator dependent and experts are few and far between.

MRI

Provides excellent anatomical detail without radiation and is often the preferred non-invasive modality. However, MRI does not provide exercise-related context.

CT Angiography (CTA)

Offers superb spatial resolution but involves radiation and contrast.

Catheter Angiography

Catheter angiography — especially with provocative manoeuvres such as hip flexion — remains the gold standard and is often used for surgical planning.

In Practice The most common approach is to perform bedside pre- and post-exercise ABPI, follow with a duplex doppler exercise study (if available), and if positive, proceed with imaging in the form of MRI or CTA.

Management

Management Approaches — From Conservative to Definitive

Conservative Reduce training volume Modify bike position Limit aero positioning May reduce symptoms Does not reverse fibrosis Endovascular Angioplasty Stenting Generally disappointing Recoil and restenosis risk Surgery Endarterectomy + patch Segment resection Arterial shortening Release fibrotic tissue Best durable outcomes Definitive for elite athletes Suitability by athlete level Recreational Competitive amateur Elite / professional Conservative may suffice Surgery usually required

Conservative Strategies

Initial measures may include reducing training volume or intensity, modifying bike fit to reduce extreme hip flexion, and limiting prolonged aerodynamic positioning.

While these may reduce symptoms in recreational athletes, they are rarely sufficient for elite riders. Importantly, conservative measures do not reverse established intimal fibrosis.

Endovascular Approaches: Usually Not the Answer

Angioplasty and stenting have been tried, but results are generally disappointing. The fibrotic lesion tends to recoil, and stents in this highly mobile region are prone to fracture or restenosis.

For high-performance athletes, these approaches are usually considered temporary or unsuitable.

Surgery: The Definitive Option for Elite Athletes

For riders wishing to return to top-level competition, surgical management remains the treatment of choice. Procedures may include endarterectomy with patch angioplasty, resection of the fibrotic segment, arterial shortening to reduce kinking, and release of surrounding fibrotic tissue.

When performed by experienced vascular surgeons familiar with athletic endofibrosis, outcomes are generally good. Many athletes return to elite competition, though careful rehabilitation and long-term follow-up are essential.

Return to Performance

Post-operative rehabilitation must be structured and conservative initially, progressing from low-intensity riding to full race demands over several months. Ongoing surveillance is important, as contralateral disease and recurrence can occur in long careers.

From a team perspective, early recognition is critical. The earlier the diagnosis, the less time lost to unexplained performance decline and compensatory injury patterns.

For Team Clinicians If an athlete reports progressive, intensity-dependent unilateral leg symptoms — particularly in the context of a normal resting exam — endofibrosis should be on the differential. Don't wait for bilateral disease to develop before investigating.

Key Take-Home Points

Not Atherosclerosis
External iliac artery intimal fibrosis is a non-atherosclerotic vascular condition — no lipid plaques, no calcification. A distinct pathology caused by mechanical stress in elite cyclists.
Intensity Dependent
Symptoms are exercise-specific and appear only above a threshold workload. Often unilateral. Easy rides and even tempo efforts may feel completely normal.
Normal Resting Exam
Resting exams are frequently normal — pulses, skin, neuro all unremarkable. Exercise testing is essential to unmask the flow limitation.
Conservative ≠ Cure
Reducing volume or modifying bike fit may help recreational athletes but rarely suffices for elite performance demands. Fibrosis is not reversed.
Surgery Is Definitive
For athletes seeking return to competition, surgery by experienced vascular surgeons offers the best chance of durable recovery and return to elite performance.

About the Author

Prof. Jeroen Swart
Prof. Jeroen Swart
S2S Co-Founder & Director | Head of Performance, UAE Team Emirates XRG
Jeroen is a professor of Sports & Exercise Medicine and Exercise Science, and co-founder of Science to Sport. With over 50 peer-reviewed publications spanning cycling physiology, performance testing and sports medicine, he brings a rare combination of clinical depth and applied coaching experience to athlete development.
He has coached leading international cyclists for close to two decades, and as Head of Performance at UAE Team Emirates XRG — the UCI's number-one ranked WorldTour team from 2023 to 2025 — has worked with three different Tour de France winners. Jeroen is also the architect of the ErgoFiT predictive bike fitting system, the only scientifically validated tool of its kind.
Credentials & Background
MBChB, MPhil (SEM), ACSEM, FFIMS, PhD. A multi-time South African national champion in XCO mountain biking, Jeroen's own competitive background gives him a first-hand understanding of the demands elite cycling places on the body — and the ways it can break down.